Phibro Animal Health (NASDAQ:PAHC) Raised to “Strong-Buy” at StockNews.com

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a report published on Thursday.

Other equities research analysts have also issued research reports about the company. JPMorgan Chase & Co. assumed coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective on the stock. Barclays increased their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Finally, Bank of America lifted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a strong buy rating to the company. According to MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $16.50.

Phibro Animal Health Stock Performance

Shares of PAHC stock opened at $23.37 on Thursday. The stock has a market cap of $946.49 million, a PE ratio of 54.35, a price-to-earnings-growth ratio of 0.60 and a beta of 0.51. Phibro Animal Health has a 52-week low of $9.49 and a 52-week high of $25.98. The business has a 50-day simple moving average of $23.32 and a 200-day simple moving average of $20.23. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

Insider Buying and Selling at Phibro Animal Health

In related news, Director E Thomas Corcoran purchased 5,000 shares of Phibro Animal Health stock in a transaction that occurred on Wednesday, September 4th. The stock was purchased at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the transaction, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. This trade represents a 25.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 50.07% of the company’s stock.

Institutional Investors Weigh In On Phibro Animal Health

Several large investors have recently bought and sold shares of the company. BNP Paribas Financial Markets lifted its position in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after acquiring an additional 729 shares in the last quarter. CWM LLC lifted its holdings in Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after purchasing an additional 1,035 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Phibro Animal Health by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock worth $200,000 after purchasing an additional 1,063 shares during the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in shares of Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after buying an additional 1,522 shares in the last quarter. Finally, Cardinal Capital Management raised its position in shares of Phibro Animal Health by 4.7% in the second quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock valued at $940,000 after buying an additional 2,520 shares during the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.